The RMR Group (RMR)
(Delayed Data from NSDQ)
$25.14 USD
+0.51 (2.07%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $25.15 +0.01 (0.04%) 7:58 PM ET
4-Sell of 5 4
A Value A Growth F Momentum A VGM
Price, Consensus and EPS Surprise
RMR 25.14 +0.51(2.07%)
Will RMR be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for RMR based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RMR
RMR Group (RMR) Reports Q3 Earnings: What Key Metrics Have to Say
RMR Group (RMR) Misses Q3 Earnings and Revenue Estimates
RMR: What are Zacks experts saying now?
Zacks Private Portfolio Services
Here's What Key Metrics Tell Us About RMR Group (RMR) Q2 Earnings
RMR Group (RMR) Q2 Earnings and Revenues Miss Estimates
Jones Lang LaSalle (JLL) Surpasses Q1 Earnings and Revenue Estimates
Other News for RMR
Rome Resources touts visible tin mineralisation at Kalayi prospect
Rome Resources Strikes Tin in Congo Prospect
The RMR Group Announces Vertex Pharmaceuticals? 15-Year Lease Renewal for 1.1 Million Square Feet in Boston?s Seaport District
RMR Group announces early renewal of Vertex Pharmaceuticals lease
Service Properties Trust Announces Second Quarter 2024 Results